Vancomycin trough concentrations in overweight or obese pediatric patients

Area of Science:

• Pediatric pharmacology
• Infectious disease management
• Clinical pharmacy

Background:

• Vancomycin is a critical antibiotic for treating serious Gram-positive infections in children.
• Accurate dosing is essential to achieve therapeutic efficacy and minimize toxicity.
• Obesity is increasingly prevalent in pediatric populations, potentially impacting drug pharmacokinetics.

Purpose of the Study:

• To compare vancomycin trough concentrations in overweight/obese pediatric patients versus normal body habitus (NBH) children.
• To evaluate the impact of total body weight (TBW)-based dosing on initial vancomycin levels in these groups.

Main Methods:

• Retrospective observational case-control study.
• Matched 42 overweight/obese pediatric patients with 84 NBH children.
• Analyzed initial vancomycin trough concentrations from electronic medical records.

Main Results:

• Overweight/obese children had significantly higher initial vancomycin trough concentrations (median 14.4 μg/ml vs 10.5 μg/ml, p<0.001).
• Higher trough concentrations (>20 μg/ml) were more frequent in overweight/obese children (p=0.016).
• Lower trough concentrations (<10 μg/ml) were more frequent in NBH children (p<0.001).

Conclusions:

• Empiric vancomycin dosing based on TBW may lead to elevated concentrations in overweight and obese pediatric patients.
• Close therapeutic drug monitoring is essential for all children, especially those who are overweight or obese.
• Current dosing strategies may require adjustment for pediatric patients with varying body compositions.